Cover
Cover | Aug. 29, 2024 |
Entity Addresses [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 29, 2024 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 000-22873 |
Entity Registrant Name | Oruka Therapeutics, Inc. |
Entity Central Index Key | 0000907654 |
Entity Tax Identification Number | 36-3855489 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 855 Oak Grove Avenue |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | Menlo Park |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94025 |
City Area Code | 650 |
Local Phone Number | 606-7910 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.001 par value |
Trading Symbol | ORKA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Former Address [Member] | |
Entity Addresses [Line Items] | |
Entity Registrant Name | ARCA biopharma, Inc. |
Entity Address, Address Line One | 10170 Church Ranch Way |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | Westminster |
Entity Address, State or Province | CO |
Entity Address, Postal Zip Code | 80021 |